drugset / Trial / NCT07553468

Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy

NCT07553468 ↗

Completed 8 enrolled Michael H Carstens
NaSingle-groupOpen-labelTreatment

Summary

This is an interventional open-label study to determine the safety and clinical performance of SVF cells in the treatment of Diabetic Peripheral Neuropathy.

Timeline

Start
2024-12-01
Primary completion
2026-02-28
Completion
2026-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Adipose-derived stromal vascular fraction cells Cell therapy 50 cells Subcutaneous